Deepika Pakianathan insider trades

Open-market stock purchases and sales by Deepika Pakianathan, Unknown at Theravance Biopharma, Inc, from SEC Form 4 filings since Jan 26, 2010.

Track record: 0% of 10 scored buys are up 5% or more since purchase, averaging -62%.

Recent trades

DateStockTradeValue
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)—
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$351K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$122K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$284K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$241K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$224K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$228K
Sep 23, 2026TBPH Theravance Biopharma, IncSold (not open market)$223K
Jun 12, 2026TBPH Theravance Biopharma, IncBought (not open market)—
Jun 12, 2026TBPH Theravance Biopharma, IncBought (not open market)—
May 21, 2026KPTI Karyopharm Therapeutics IncBought (not open market)—
Feb 26, 2026MREO Mereo BioPharma Group plcBought (not open market)—

Companies traded

  • TBPH Theravance Biopharma, Inc: other filings, last Sep 23, 2026
  • KPTI Karyopharm Therapeutics Inc: 10 buys, 18 sales, last May 21, 2026
  • MREO Mereo BioPharma Group plc: 1 sale, last Feb 26, 2026
  • CALA Calithera Biosciences, Inc: 2 buys, 2 sales, last Jan 27, 2023
  • PRDS Pardes Biosciences, Inc: other filings, last Dec 23, 2021
  • OMED OncoMed Pharmaceuticals Inc: 8 buys, last Apr 23, 2019
  • ALDR Alder Biopharmaceuticals Inc: 2 buys, last May 23, 2018
  • ALXA Alexza Pharmaceuticals Inc: other filings, last Jun 21, 2016

Get free alerts when Deepika Pakianathan files a new trade →